Utilidad de atazanavir en poblaciones especiales
Utility of atazanavir in special populations
Antonio Antela López
Autor para correspondencia
antonio.antela.lopez@sergas.es
Correspondencia: Dr. A. Antela López. Unidad de VIH-Enfermedades Infecciosas. Servicio de Medicina Interna. Hospital Clínico Universitario de Santiago de Compostela. Avda. da Choupana, s/n. 15706 Santiago de Compostela. A Coruña. España.
Correspondencia: Dr. A. Antela López. Unidad de VIH-Enfermedades Infecciosas. Servicio de Medicina Interna. Hospital Clínico Universitario de Santiago de Compostela. Avda. da Choupana, s/n. 15706 Santiago de Compostela. A Coruña. España.
Unidad de VIH-Enfermedades Infecciosas. Servicio de Medicina Interna. Hospital Clínico Universitario de Santiago de Compostela. La Coruña. España
Leído
1925
Vecesse ha leído el artículo
829
Total PDF
1096
Total HTML
Compartir estadísticas
array:23 [ "pii" => "S0213005X08766217" "issn" => "0213005X" "doi" => "10.1016/S0213-005X(08)76621-7" "estado" => "S300" "fechaPublicacion" => "2008-12-01" "aid" => "76621" "copyright" => "Elsevier España S.L.. Todos los derechos reservados" "copyrightAnyo" => "2008" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2008;26 Supl 17:49-54" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1265 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 805 "PDF" => 452 ] ] "itemSiguiente" => array:18 [ "pii" => "S0213005X08766229" "issn" => "0213005X" "doi" => "10.1016/S0213-005X(08)76622-9" "estado" => "S300" "fechaPublicacion" => "2008-12-01" "aid" => "76622" "copyright" => "Elsevier España S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2008;26 Supl 17:55-67" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1518 "formatos" => array:3 [ "EPUB" => 10 "HTML" => 958 "PDF" => 550 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Utilidad clínica de atazanavir" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "55" "paginaFinal" => "67" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical utility of atazanavir" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Esteban Ribera Pascuet, Adrià Curran" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Esteban Ribera" "apellidos" => "Pascuet" ] 1 => array:2 [ "nombre" => "Adrià" "apellidos" => "Curran" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X08766229?idApp=UINPBA00004N" "url" => "/0213005X/0000002600000S17/v1_201305090109/S0213005X08766229/v1_201305090109/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0213005X08766205" "issn" => "0213005X" "doi" => "10.1016/S0213-005X(08)76620-5" "estado" => "S300" "fechaPublicacion" => "2008-12-01" "aid" => "76620" "copyright" => "Elsevier España S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2008;26 Supl 17:45-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1896 "formatos" => array:3 [ "EPUB" => 11 "HTML" => 1327 "PDF" => 558 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Atazanavir en la coinfección por VIH y virus de la hepatitis B y/o C" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "45" "paginaFinal" => "48" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antonio Rivero, Ángela Camacho, Inés Pérez-Camacho, Julián Torre-Cisneros" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Antonio" "apellidos" => "Rivero" ] 1 => array:2 [ "nombre" => "Ángela" "apellidos" => "Camacho" ] 2 => array:2 [ "nombre" => "Inés" "apellidos" => "Pérez-Camacho" ] 3 => array:2 [ "nombre" => "Julián" "apellidos" => "Torre-Cisneros" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X08766205?idApp=UINPBA00004N" "url" => "/0213005X/0000002600000S17/v1_201305090109/S0213005X08766205/v1_201305090109/es/main.assets" ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Utilidad de atazanavir en poblaciones especiales" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "49" "paginaFinal" => "54" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Antonio Antela López" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Antonio Antela" "apellidos" => "López" "email" => array:1 [ 0 => "antonio.antela.lopez@sergas.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor1" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Unidad de VIH-Enfermedades Infecciosas. Servicio de Medicina Interna. Hospital Clínico Universitario de Santiago de Compostela. La Coruña. España" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "⁎" "correspondencia" => "Correspondencia: Dr. A. Antela López. Unidad de VIH-Enfermedades Infecciosas. Servicio de Medicina Interna. Hospital Clínico Universitario de Santiago de Compostela. Avda. da Choupana, s/n. 15706 Santiago de Compostela. A Coruña. España." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Utility of atazanavir in special populations" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec137571" "palabras" => array:8 [ 0 => "Atazanavir" 1 => "Embarazo" 2 => "Lipodistrofia" 3 => "Riesgo cardiovascular" 4 => "Insuficiencia renal" 5 => "Niños" 6 => "Inmigrantes" 7 => "Metadona" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec137570" "palabras" => array:8 [ 0 => "Atazanavir" 1 => "Pregnancy" 2 => "Lipodystrophy" 3 => "Cardiovascular risk" 4 => "Renal failure" 5 => "Children" 6 => "Immigrants" 7 => "Methadone" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">En el momento actual, con el tratamiento antirretroviral (TAR) se consigue prolongar la supervivencia de las personas que viven con virus de la inmunodeficiencia humana (VIH) de forma indefinida. Debido a ello, nos encontramos cada vez con mayor frecuencia con problemas específicos que anteriormente no daba tiempo a desarrollar o no tenían la importancia que ahora alcanzan, y que configuran, a poblaciones especiales de pacientes. Ejemplos de situaciones que caracterizan a estas poblaciones especiales son: la coinfección por virus de la hepatitis B y/o C, el embarazo, la lipodistrofia, el riesgo cardiovascular, la insuficiencia renal, el tratamiento de los niños y adolescentes, la atención a personas desplazadas (inmigrantes) y el tratamiento de personas que estén recibiendo tratamiento sustitutivo con metadona, entre otras. En el presente artículo revisamos el papel que puede tener atazanavir en el TAR de pacientes en las situaciones mencionadas, excepto las que ya son tratadas específicamente en otros artículos, tal como la coinfección por virus de la hepatitis B y/o C.</p>" ] "en" => array:1 [ "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">ART (antiretroviral therapy) currently continues to indefinitely prolong the survival of patients who live with HIV. Due to this, we are increasingly faced with specific problems that previously did not have time to develop or did not have the importance that they have now, and which are related to the existence of special patient populations. Examples of situations that characterise these special populations are: co-infection with hepatitis virus B and/or C, pregnancy, lipodystrophy, cardiovascular risk, renal failure, treatment of children and adolescents, immigrant health care, and the management of patients receiving methadone replacement therapy, among others. In this article we review the role that Atazanavir (ATV) can play in the ART of patients in the situations mentioned, except those that are already dealt with specifically in other articles, such as co-infection by hepatitis virus B and/or C.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:35 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.M. Garcia" 1 => "L.A. Kalish" 2 => "J. Pitt" 3 => "H. Minkoff" 4 => "T.C. Quinn" 5 => "S.K. Burchett" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199908053410602" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1999" "volumen" => "341" "paginaInicial" => "394" "paginaFinal" => "402" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10432324" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/ml" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.P. Ioannidis" 1 => "E.J. Abrams" 2 => "A. Ammann" 3 => "M. Bulterys" 4 => "J.J. Goedert" 5 => "L. Gray" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Infect Dis" "fecha" => "2001" "volumen" => "183" "paginaInicial" => "539" "paginaFinal" => "545" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Ripamonti" 1 => "D. Cattaneo" 2 => "F. Maggiolo" 3 => "M. Airoldi" 4 => "L. Frigerio" 5 => "P. Bertuletti" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "AIDS" "fecha" => "2007" "volumen" => "21" "paginaInicial" => "2409" "paginaFinal" => "2415" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atazanavir in pregnancy: influence on neonatal hyperbilirubinemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Ferreira" 1 => "C. Floch-Tudal" 2 => "F. Meier" 3 => "G. Peytavin" 4 => "J. Treluyer" 5 => "V. Jullien" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "15th Conference on Retroviruses and Opportunistic Infections; february 3-6" "conferencia" => "Boston, MA" "serieFecha" => "2008" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atazanavir use in pregnancy: a report of 33 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Natha" 1 => "P. Hay" 2 => "G. Taylor" 3 => "G. Brook" 4 => "L. Sarner" 5 => "L. Cunningham" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "14th Conference on Retoviruses and Opportunistic Infections; february 25-28" "conferencia" => "Los Angeles, CA" "serieFecha" => "2007" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Steady state pharmacokinetics and safety of atazanavir after treatment with ATV 300 mg once-daily/ritonavir 100 mg once-daily + ZDV/3TC during the third trimester in HIV+ women" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Eley" 1 => "E. Vandeloise" 2 => "M. Child" 3 => "F. Conradie" 4 => "C. Zorrilla" 5 => "D. Josipovic" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "15th Conference on Retroviruses and Opportunistic Infections; february 3-6" "conferencia" => "Boston, MA" "serieFecha" => "2008" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "DHHS Panel. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Diciembre, 2007. Disponible en: <a class="elsevierStyleInterRef" href="http://aidsinfo.nih.gov/">http://AIDSinfo.nih.gov</a>" ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Recomendaciones de la SPNS/GESIDA/SEGO/AEP. Recomendaciones para el seguimiento de la infección por el VIH con relación a la reproducción, el embarazo y la prevención de la transmisión vertical 2007. Disponible en: www.gesida.seimc.org." ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Carr" 1 => "K. Samaras" 2 => "S. Burton" 3 => "Law" 4 => "J. Freund" 5 => "D.J. Chisholm" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "1998" "volumen" => "12" "paginaInicial" => "F51" "paginaFinal" => "F58" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9619798" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Carr Millar" 1 => "M. Law" 2 => "D.A. Cooper" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2000" "volumen" => "14" "paginaInicial" => "F25" "paginaFinal" => "32" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10716495" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atazanavir: a review of its use in the management of HIV infection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T. Swainston Harrison" 1 => "L.J. Scott" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2005" "volumen" => "65" "paginaInicial" => "2309" "paginaFinal" => "2336" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16266202" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Nguyen" 1 => "A. Calmy" 2 => "V. Schiffer" 3 => "E. Bernasconi" 4 => "M. Battegay" 5 => "M. Opravil" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-1293.2007.00537.x" "Revista" => array:6 [ "tituloSerie" => "HIV Med" "fecha" => "2008" "volumen" => "9" "paginaInicial" => "142" "paginaFinal" => "150" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18218001" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G. Haerter" 1 => "B.J. Manfras" 2 => "M. Mueller" 3 => "P. Kern" 4 => "A. Trein" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2004" "volumen" => "18" "paginaInicial" => "952" "paginaFinal" => "955" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15060446" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combination antiretroviral therapy and the risk of myocardial infarction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Friis-Moller" 1 => "C.A. Sabin" 2 => "R. Weber" 3 => "A. d’Arminio Monforte" 4 => "W.M. El-Sadr" 5 => "P. Reiss" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa030218" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2003" "volumen" => "349" "paginaInicial" => "1993" "paginaFinal" => "2003" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14627784" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Class of antiretroviral drugs and the risk of myocardial infraction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Friis-Moller" 1 => "P. Reiss" 2 => "C.A. Sabin" 3 => "R. Weber" 4 => "A. Monforte" 5 => "W. El-Sadr" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa062744" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2007" "volumen" => "356" "paginaInicial" => "1723" "paginaFinal" => "1735" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17460226" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "EACS Guidelines. Disponible en: http://www.eacs.eu." ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Doseranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naïve subjects: 48-week results" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Murphy" 1 => "I. Sanne" 2 => "P. Cahn" 3 => "P. Phanuphak" 4 => "L. Percival" 5 => "T. Kelleher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.aids.0000096930.51231.5d" "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2003" "volumen" => "17" "paginaInicial" => "2603" "paginaFinal" => "2614" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14685054" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atazanavir plus ritonavir or saquinavir and lopinavir/ritonavir in patients experiencing multiple virological failures" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Johnson" 1 => "B. Grinsztejn" 2 => "C. Rodríguez" 3 => "J. Coco" 4 => "E. DeJesus" 5 => "A. Lazzarin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "AIDS" "fecha" => "2005" "volumen" => "19" "paginaInicial" => "685" "paginaFinal" => "694" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ ritonavir in patients with multiple virological failures" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Johnson" 1 => "B. Grinsztejn" 2 => "C. Rodríguez" 3 => "J. Coco" 4 => "E. DeJesus" 5 => "A. Lazzarin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.aids.0000216371.76689.63" "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2006" "volumen" => "20" "paginaInicial" => "711" "paginaFinal" => "718" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16514301" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Switching to atazanavir improves metabolic disorders in antiretroviral- experienced patients with severe hyperlipidemia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "U. Möbius" 1 => "M. Lubach-Ruitman" 2 => "B. Castro-Frenzel" 3 => "M. Stoll" 4 => "S. Esser" 5 => "E. Voigt" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Acquir Immune Defic Syndr" "fecha" => "2005" "volumen" => "39" "paginaInicial" => "174" "paginaFinal" => "180" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15905733" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eficacy and safety of once-daily Atazanavir/ritonavir compared to twice-daily Lopinavir/ritonavir, each in combination with Tenofovir and Emtricitabine in ARV-naïve HIV-1-infected subjects: the CASTLE study, 48-week results" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Molina" 1 => "J. Andrade-Villanueva" 2 => "J. Echevarria" 3 => "P. Chetchotisakd" 4 => "J. Corral" 5 => "N. David" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:2 [ "titulo" => "15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 febrero" "serieFecha" => "2008" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.A. Noor" 1 => "O.P. Flint" 2 => "J.F. Maa" 3 => "R.A. Parker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.aids.0000244200.11006.55" "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2006" "volumen" => "20" "paginaInicial" => "1813" "paginaFinal" => "1821" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16954722" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine in antiretroviral naïve HIV-infecetd patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Jemsek" 1 => "E. Arathoon" 2 => "M. Arlotti" 3 => "C. Perez" 4 => "N. Sosa" 5 => "V. Pokrovskiy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/498505" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2006" "volumen" => "42" "paginaInicial" => "273" "paginaFinal" => "280" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16355341" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics of Atazanavir in severely renally impaired subjects including those on hemodialysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Agarwala" 1 => "T. Eley" 2 => "M. Child" 3 => "Y. Wang" 4 => "A. Persson" 5 => "D. Filoramo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "8th International Workshop on Clinical Pharmacology of HIV Therapy" "conferencia" => "Budapest, Hungría, 16-18 Abril" "serieFecha" => "2007" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment responses to Atazanavir-containing HAART in a drug-naïve paediatrics population in South Africa" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Meyers" 1 => "R. Rutstein" 2 => "P. Samson" 3 => "A. Violari" 4 => "M. Palmer" 5 => "J. Kiser" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:2 [ "titulo" => "15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3-6 Febrero" "serieFecha" => "2008" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Situación de la epidemia de SIDA (versión española, diciembre de 2007)" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "ONUSIDA/07" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2007" "editorial" => "OMS" "editorialLocalizacion" => "Geneva" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Encuesta hospitalaria de pacientes VIH/SIDA. Resultados 2006. Análisis de la evolución 1996-2006. Disponible en: http://www.msc.es/ciudadanos/enfLesiones/enfTransmisibles.htm." ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Infección por VIH y SIDA en España Plan Multisectorial. Indicadores 2006. Disponible en: http://www.msc.es/ciudadanos/enfLesiones/enfTransmisibles/sida/planesEstrat/indicadores2006_3.pdf 2006." ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Plan Nacional sobre Drogas. Disponible en: <a class="elsevierStyleInterRef" href="http://www.pnsd.msc.es/">http://www.pnsd.msc.es</a>" ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infections" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.L. Schwartz" 1 => "A.B. Brechbühl" 2 => "P. Kahl" 3 => "M.A. Miller" 4 => "P.A. Selwyn" 5 => "G.H. Friedland" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Acquir Immune Defic Syndr" "fecha" => "1992" "volumen" => "5" "paginaInicial" => "619" "paginaFinal" => "626" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib31" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.M. Clarke" 1 => "F. Mulcahy" 2 => "J. Tjia" 3 => "H.E. Reynolds" 4 => "S.E. Gibbons" 5 => "M.G. Barry" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/322519" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2001" "volumen" => "33" "paginaInicial" => "1595" "paginaFinal" => "1597" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11568856" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib32" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.M. Clarke" 1 => "F.M. Mulcahy" 2 => "J. Tjia" 3 => "H.E. Reynolds" 4 => "S.E. Gibbons" 5 => "M.G. Barry" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Clin Pharmacol" "fecha" => "2001" "volumen" => "51" "paginaInicial" => "213" "paginaFinal" => "217" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11298066" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib33" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic Drug Interactions Between Opioid Agonist Therapy and Antiretroviral Medications: Implications and Management for Clinical Practice" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.D. Bruce" 1 => "F.L. Altice" 2 => "M.N. Gourevitch" 3 => "G.H. Friedland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.qai.0000219769.89679.ec" "Revista" => array:6 [ "tituloSerie" => "J Acquir Immune Defic Syndr" "fecha" => "2006" "volumen" => "41" "paginaInicial" => "563" "paginaFinal" => "572" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16652030" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib34" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug interactions in the management of HIV infection: an update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.M. Robertson" 1 => "S.R. Penzak" 2 => "A.K. Pau" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1517/14656566.8.17.2947" "Revista" => array:6 [ "tituloSerie" => "Expert Opin Pharmacother" "fecha" => "2007" "volumen" => "8" "paginaInicial" => "2947" "paginaFinal" => "2963" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18001255" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib35" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lack of an effect of Atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Friedland" 1 => "L. Andrews" 2 => "T. Schreibman" 3 => "S. Agarwala" 4 => "L. Daley" 5 => "M. Child" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2005" "volumen" => "19" "paginaInicial" => "1635" "paginaFinal" => "1641" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16184033" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/0213005X/0000002600000S17/v1_201305090109/S0213005X08766217/v1_201305090109/es/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/0213005X/0000002600000S17/v1_201305090109/S0213005X08766217/v1_201305090109/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X08766217?idApp=UINPBA00004N" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 0 | 1 | 1 |
| 2024 Octubre | 3 | 4 | 7 |
| 2024 Septiembre | 7 | 3 | 10 |
| 2024 Agosto | 4 | 3 | 7 |
| 2024 Julio | 9 | 4 | 13 |
| 2024 Junio | 7 | 2 | 9 |
| 2024 Mayo | 6 | 4 | 10 |
| 2024 Abril | 3 | 3 | 6 |
| 2024 Marzo | 10 | 7 | 17 |
| 2024 Febrero | 6 | 4 | 10 |
| 2024 Enero | 5 | 3 | 8 |
| 2023 Diciembre | 4 | 8 | 12 |
| 2023 Noviembre | 5 | 5 | 10 |
| 2023 Octubre | 3 | 11 | 14 |
| 2023 Septiembre | 2 | 5 | 7 |
| 2023 Agosto | 2 | 18 | 20 |
| 2023 Julio | 4 | 8 | 12 |
| 2023 Junio | 4 | 4 | 8 |
| 2023 Mayo | 2 | 10 | 12 |
| 2023 Abril | 2 | 3 | 5 |
| 2023 Marzo | 2 | 3 | 5 |
| 2023 Febrero | 2 | 8 | 10 |
| 2023 Enero | 1 | 7 | 8 |
| 2022 Diciembre | 6 | 9 | 15 |
| 2022 Noviembre | 10 | 17 | 27 |
| 2022 Octubre | 6 | 9 | 15 |
| 2022 Septiembre | 5 | 8 | 13 |
| 2022 Agosto | 6 | 10 | 16 |
| 2022 Julio | 6 | 7 | 13 |
| 2022 Junio | 5 | 5 | 10 |
| 2022 Mayo | 6 | 5 | 11 |
| 2022 Abril | 9 | 13 | 22 |
| 2022 Marzo | 8 | 10 | 18 |
| 2022 Febrero | 4 | 3 | 7 |
| 2022 Enero | 5 | 5 | 10 |
| 2021 Diciembre | 4 | 5 | 9 |
| 2021 Noviembre | 3 | 6 | 9 |
| 2021 Octubre | 8 | 10 | 18 |
| 2021 Septiembre | 7 | 8 | 15 |
| 2021 Agosto | 7 | 9 | 16 |
| 2021 Julio | 7 | 3 | 10 |
| 2021 Junio | 3 | 4 | 7 |
| 2021 Mayo | 2 | 3 | 5 |
| 2021 Abril | 24 | 12 | 36 |
| 2021 Marzo | 7 | 5 | 12 |
| 2021 Febrero | 7 | 10 | 17 |
| 2021 Enero | 5 | 8 | 13 |
| 2020 Diciembre | 5 | 5 | 10 |
| 2020 Noviembre | 4 | 10 | 14 |
| 2020 Octubre | 1 | 4 | 5 |
| 2020 Septiembre | 6 | 7 | 13 |
| 2020 Agosto | 3 | 5 | 8 |
| 2020 Julio | 7 | 12 | 19 |
| 2020 Junio | 3 | 10 | 13 |
| 2020 Mayo | 3 | 6 | 9 |
| 2020 Abril | 2 | 3 | 5 |
| 2020 Marzo | 2 | 2 | 4 |
| 2020 Febrero | 3 | 10 | 13 |
| 2020 Enero | 0 | 13 | 13 |
| 2019 Diciembre | 4 | 8 | 12 |
| 2019 Noviembre | 3 | 3 | 6 |
| 2019 Octubre | 1 | 2 | 3 |
| 2019 Septiembre | 1 | 2 | 3 |
| 2019 Agosto | 1 | 4 | 5 |
| 2019 Julio | 6 | 6 | 12 |
| 2019 Junio | 5 | 43 | 48 |
| 2019 Mayo | 26 | 61 | 87 |
| 2019 Abril | 2 | 18 | 20 |
| 2019 Marzo | 1 | 5 | 6 |
| 2019 Febrero | 1 | 15 | 16 |
| 2019 Enero | 1 | 1 | 2 |
| 2018 Diciembre | 2 | 3 | 5 |
| 2018 Noviembre | 1 | 0 | 1 |
| 2018 Octubre | 4 | 6 | 10 |
| 2018 Septiembre | 2 | 3 | 5 |
| 2018 Agosto | 1 | 14 | 15 |
| 2018 Julio | 1 | 5 | 6 |
| 2018 Junio | 0 | 4 | 4 |
| 2018 Mayo | 3 | 10 | 13 |
| 2018 Abril | 4 | 1 | 5 |
| 2018 Marzo | 1 | 3 | 4 |
| 2018 Febrero | 0 | 1 | 1 |
| 2018 Enero | 5 | 2 | 7 |
| 2017 Diciembre | 0 | 1 | 1 |
| 2017 Noviembre | 3 | 0 | 3 |
| 2017 Octubre | 1 | 4 | 5 |
| 2017 Septiembre | 4 | 1 | 5 |
| 2017 Agosto | 2 | 0 | 2 |
| 2017 Julio | 0 | 1 | 1 |
| 2017 Junio | 1 | 9 | 10 |
| 2017 Mayo | 3 | 1 | 4 |
| 2017 Abril | 7 | 1 | 8 |
| 2017 Marzo | 9 | 20 | 29 |
| 2017 Febrero | 5 | 1 | 6 |
| 2017 Enero | 2 | 0 | 2 |
| 2016 Diciembre | 1 | 0 | 1 |
| 2016 Noviembre | 2 | 2 | 4 |
| 2016 Octubre | 12 | 1 | 13 |
| 2016 Septiembre | 9 | 1 | 10 |
| 2016 Agosto | 9 | 0 | 9 |
| 2016 Julio | 6 | 2 | 8 |
| 2016 Junio | 7 | 16 | 23 |
| 2016 Mayo | 8 | 7 | 15 |
| 2016 Abril | 8 | 9 | 17 |
| 2016 Marzo | 14 | 7 | 21 |
| 2016 Febrero | 5 | 8 | 13 |
| 2016 Enero | 13 | 6 | 19 |
| 2015 Diciembre | 8 | 17 | 25 |
| 2015 Noviembre | 6 | 7 | 13 |
| 2015 Octubre | 7 | 7 | 14 |
| 2015 Septiembre | 8 | 5 | 13 |
| 2015 Agosto | 9 | 3 | 12 |
| 2015 Julio | 7 | 3 | 10 |
| 2015 Junio | 2 | 2 | 4 |
| 2015 Mayo | 5 | 2 | 7 |
| 2015 Abril | 6 | 7 | 13 |
| 2015 Marzo | 4 | 1 | 5 |
| 2015 Febrero | 2 | 6 | 8 |
| 2015 Enero | 15 | 2 | 17 |
| 2014 Diciembre | 14 | 4 | 18 |
| 2014 Noviembre | 12 | 2 | 14 |
| 2014 Octubre | 19 | 2 | 21 |
| 2014 Septiembre | 17 | 1 | 18 |
| 2014 Agosto | 13 | 2 | 15 |
| 2014 Julio | 18 | 1 | 19 |
| 2014 Junio | 14 | 3 | 17 |
| 2014 Mayo | 7 | 2 | 9 |
| 2014 Abril | 6 | 2 | 8 |
| 2014 Marzo | 14 | 1 | 15 |
| 2014 Febrero | 11 | 0 | 11 |
| 2014 Enero | 16 | 3 | 19 |
| 2013 Diciembre | 15 | 5 | 20 |
| 2013 Noviembre | 13 | 3 | 16 |
| 2013 Octubre | 9 | 6 | 15 |
| 2013 Septiembre | 7 | 8 | 15 |
| 2013 Agosto | 9 | 4 | 13 |
| 2013 Julio | 16 | 1 | 17 |
| 2008 Diciembre | 288 | 0 | 288 |
Mostrar todo
